Pharmac chief medical officer David Hughes says Pharmac’s COVID-19 Treatments Advisory Group made the decision to expand the criteria based on substantial feedback
We want to make sure that healthcare practitioners can identify who would benefit from accessing these treatments. We hope the updated criteria and he